Syros Pharmaceuticals, Inc. ( SYRS) - Stock Earnings
SYRS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | -3.7 million USD | — USD |
| 2024Q2 | -23.3 million USD | — USD |
| 2024Q3 | -6.4 million USD | — USD |
SYRS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021 | -90.5 million USD | 23.5 million USD |
| 2022 | -49.3 million USD | 14.9 million USD |
| 2023 | -164.6 million USD | 9.9 million USD |
SYRS
Price: $0
52 week price:
Earnings Per Share: -3.07 USD
P/E Ratio: -0.01
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 234220
Ebitda: -13.6 millionMarket Capitalization: 5366